Connect your AI

AdaptHealth AHCO Respiratory Health — Goodwill from acquisitions (note 3)

Other segment segments

Wellness at Home

$11.66M—

Sleep Health

$3.63M—

Diabetes Health

$0—

Similar metrics at other companies

CTSHHealth Sciences — Goodwill, Acquired During Period

$0-100%

AVAHHome Health And Hospice — Goodwill Acquired

$0—

UHSBehavioral Health Services — Goodwill Acquired

$5.45M—

MDTReportable Segments — Goodwill as a result of acquisitions

$138.75M+414%

MDTOther Operating Segments — Goodwill as a result of acquisitions

$0—

FULHygiene Health And Consumable Adhesives — Goodwill Acquired

$1.05M-98.9%

Other financials

Income statement

Revenue$819.8M+5.4%

Gross profit$111.5M-7.4%

Operating income$5.5M-76.3%

Net income-$16.0M-123%

EPS (diluted)-$0.12-140%

Balance sheet

Cash & equivalents$48.0M-10.6%

Total debt$2.0B-4.9%

Total equity$1.5B-3.9%

Total assets$4.4B-0.3%

Cash flow

Operating cash flow$93.7M-1.9%

CapEx$121.2M+26.8%

Free cash flow-$27.5M-47,297%

Valuation

Market cap$1.36B+20.5%

Enterprise value$3.32B+4.3%

P/S0.4×+0.1×

Profitability

Gross margin18.3%-1.6pp

Operating margin8%+6.9pp

Net margin-2.4%-5.1pp

FCF margin5.8%-2.6pp

Returns & leverage

Return on equity-5.2%-10.8pp

Debt / equity1.3×0.0×

Current ratio0.9×-0.4×

Where this comes from

Reported directly by AdaptHealth in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The official record: AdaptHealth’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about AdaptHealth's respiratory health — goodwill from acquisitions (note 3).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is AdaptHealth's respiratory health — goodwill from acquisitions (note 3)?: AdaptHealth (AHCO) reported respiratory health — goodwill from acquisitions (note 3) of $10.65M in Q1 2026.
What does respiratory health — goodwill from acquisitions (note 3) mean?: This specifically tracks the incremental goodwill recognized during the current period resulting from new business acquisitions within the respiratory health segment. It highlights the company's inorganic growth strategy and the valuation of recent market expansions.